V. Cartsos

Oral cancer treatment costs in Greece and the effect of advanced disease

A. Vamvakidis, A. Zavras, D. Zavras, 2002, BMC public health.

Bisphosphonates and time to osteonecrosis development.

A. Zavras, V. Cartsos, P. Palaska, 2009, The oncologist.

Adverse drug and device reactions in the oral cavity: surveillance and reporting.

A. Zavras, V. Cartsos, Gregory E. Rosenberg, 2013, Journal of the American Dental Association.

Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3.

Yufeng Shen, A. Floratos, P. Nicoletti, 2012, The oncologist.

Antiretroviral Prophylaxis and the Risk of Cleft Lip and Palate: Preliminary Signal Detection in the Food and Drug Administration's Adverse Events Reporting System Database

A. Zavras, V. Cartsos, P. Palaska, 2012, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.

A. Zavras, Shao Zhu, V. Cartsos, 2008, Journal of the American Dental Association.

Factors associated with delay in the diagnosis of oral cancer.

C. Douglass, S. Diehl, W. Pitiphat, 2002, Journal of dental research.

Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk

Tianxia Wu, C. Douglass, S. Diehl, 2002, International journal of cancer.

Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans.

Tianxia Wu, C. Douglass, S. Diehl, 2003, Cancer research.

Factors Associated with Delay in the Diagnosis of Oral Cancer

C. Douglass, S. Diehl, W. Pitiphat, 2002 .

Surveillance and reporting

A. Zavras, V. Cartsos, Gregory E. Rosenberg, 2013 .